ADEM (Acute Disseminated Encephalomyelitis): MRI Diagnosis, CT Imaging Findings, Differential Diagnosis, and Modern Treatment

 

A Child Who Suddenly Could No Longer Walk

Imagine being a healthy 10-year-old child.

No chronic illness.

No neurological disease.

No significant medical history.

Then, over only one week, your legs become weak.

Walking becomes impossible.

You begin experiencing numbness.

Soon afterward, urinary retention develops.

This alarming clinical scenario represents one of the most challenging emergency diagnoses in pediatric neuroradiology.

The disease?

Acute Disseminated Encephalomyelitis (ADEM).

Although rare, ADEM is a neurological emergency because delayed recognition may lead to irreversible neurological injury. Fortunately, modern medical imaging, especially MRI, enables radiologists to identify characteristic inflammatory demyelinating lesions before permanent damage occurs.

The present case illustrates how radiology, pathology, and multidisciplinary treatment converge to establish the diagnosis and guide life-saving therapy. The patient's presentation, imaging findings, cerebrospinal fluid analysis, and treatment course are summarized from the attached case report.


What Is Acute Disseminated Encephalomyelitis (ADEM)?

ADEM is an acute autoimmune inflammatory demyelinating disorder of the central nervous system (CNS).

Instead of attacking viruses or bacteria, the immune system mistakenly attacks myelin, the protective insulating layer surrounding nerve fibers.

Loss of myelin dramatically slows electrical conduction throughout the brain and spinal cord.

Unlike Multiple Sclerosis (MS), ADEM is usually monophasic, meaning it occurs as a single inflammatory episode rather than recurring attacks.


Why Does Myelin Matter?

Think of nerve fibers as electrical wires.

The myelin sheath functions like plastic insulation.

When insulation is stripped away:

  • electrical impulses leak
  • nerve conduction slows
  • muscles weaken
  • sensation changes
  • vision becomes impaired
  • coordination deteriorates

MRI beautifully visualizes these injured white matter pathways.


Pathophysiology

Although the exact mechanism remains incompletely understood, current evidence suggests that ADEM results from an aberrant immune response triggered by environmental exposure.

Common triggers include

  • viral infections
  • bacterial infections
  • influenza
  • Epstein-Barr virus
  • Mycoplasma pneumoniae
  • measles
  • varicella
  • vaccinations (rare)

The immune system generates activated T lymphocytes capable of crossing the blood-brain barrier.

These inflammatory cells attack myelin proteins through molecular mimicry.

This produces:

  • perivenular inflammation
  • macrophage infiltration
  • myelin destruction
  • relative axonal preservation
  • widespread edema

Histopathologic examination in the presented case demonstrated extensive macrophage-rich inflammatory infiltrates, severe demyelination, and perivascular lymphocytic aggregates, findings that strongly supported ADEM.


Epidemiology

ADEM is uncommon but represents one of the most important inflammatory neurological diseases encountered in children.

Typical characteristics include:

FeatureTypical Finding
Peak age5–10 years
SexSlight male predominance
Annual incidenceApproximately 0.2–0.8 per 100,000
Most common populationChildren
Adult casesLess common

Approximately 70–80% of patients report a recent infection occurring one to four weeks before symptom onset.

Vaccination-associated ADEM has been reported but remains extremely rare. The attached case describes neurological symptoms beginning 16 days after the patient's second mRNA COVID-19 vaccination; however, temporal association alone does not establish causation.


Clinical Presentation

ADEM develops rapidly.

Symptoms often progress over hours to several days.

Unlike many neurological disorders, patients frequently present with multiple neurological deficits simultaneously.

Common manifestations include:

Motor Symptoms

  • Limb weakness
  • Difficulty walking
  • Paralysis
  • Hyperreflexia

Sensory Symptoms

  • Numbness
  • Tingling
  • Burning sensations

Brain Symptoms

  • Headache
  • Confusion
  • Encephalopathy
  • Seizures

Cranial Nerve Symptoms

  • Diplopia
  • Facial weakness
  • Visual field deficits

Spinal Cord Symptoms

  • Urinary retention
  • Bowel dysfunction
  • Sensory level
  • Long tract signs

The child described in this case developed:

  • progressive lower-extremity weakness
  • paresthesia
  • urinary retention
  • right visual field defect
  • mild hyperreflexia
  • inability to ambulate

Neurological examination localized pathology involving both the brain and spinal cord.


Initial Diagnostic Evaluation

The first priority is excluding immediately life-threatening disorders.

Emergency physicians typically order:

  • Complete blood count
  • Comprehensive metabolic panel
  • ESR
  • CRP
  • Infectious work-up
  • Viral PCR
  • Lumbar puncture
  • Brain imaging

In this patient:

  • CBC normal
  • ESR normal
  • CRP normal
  • Viral PCR negative
  • CSF showed isolated leukocytosis
  • Autoimmune antibodies, including MOG and AQP4, were negative
  • Infectious CSF studies were negative

These findings substantially narrowed the differential diagnosis.


Why MRI Is the Gold Standard

Although CT is frequently performed first during emergency diagnosis, MRI is vastly superior for detecting inflammatory demyelinating lesions.

MRI provides:

  • excellent white matter contrast
  • lesion characterization
  • enhancement assessment
  • diffusion imaging
  • spinal cord evaluation

Consequently, MRI remains the imaging modality of choice for suspected ADEM. The case demonstrated multiple characteristic brain lesions and a long-segment thoracic spinal cord lesion on contrast-enhanced MRI.


Figure 1. Initial Brain MRI

Radiologic Interpretation

The initial brain MRI demonstrates multiple bilateral asymmetric T2/FLAIR hyperintense lesions involving the subcortical and deep cerebral white matter.

Post-contrast T1-weighted imaging reveals incomplete peripheral rim enhancement, reflecting active inflammation.

Diffusion-weighted imaging (DWI) demonstrates prominent peripheral diffusion restriction, suggesting highly active inflammatory demyelination. These imaging features are characteristic of ADEM, although diffusion restriction is relatively uncommon and may indicate more severe disease.

Figure 1. Initial brain MRI showing multiple asymmetric subcortical and deep white matter FLAIR hyperintense lesions, incomplete peripheral contrast enhancement, and avid peripheral diffusion restriction, consistent with active inflammatory demyelination.


Figure 2. Initial Thoracic Spine MRI

Radiologic Interpretation

Sagittal STIR imaging demonstrates a long-segment, non-expansile intramedullary thoracic spinal cord lesion extending across multiple vertebral levels.

Post-contrast imaging reveals partial enhancement of the lesion, supporting active inflammatory involvement rather than neoplasm.

Longitudinally extensive spinal cord lesions strongly support inflammatory demyelinating disorders such as ADEM, particularly when combined with multifocal brain lesions.

Figure 2. Initial thoracic spine MRI demonstrates a longitudinally extensive intramedullary lesion with partial contrast enhancement, characteristic of inflammatory demyelination involving the spinal cord.


Why These Images Matter

For neuroradiologists, the combination of:

  • multifocal white matter lesions
  • incomplete ring enhancement
  • bilateral asymmetric distribution
  • deep white matter involvement
  • longitudinal spinal cord lesion

strongly raises suspicion for ADEM, while still requiring careful exclusion of mimicking conditions such as multiple sclerosis, primary CNS lymphoma, tumefactive demyelination, and posterior reversible encephalopathy syndrome (PRES).

CT Imaging Findings in ADEM

Although MRI is the imaging modality of choice, CT scan diagnosis remains the first-line examination in many emergency departments because it is rapid, widely available, and effective at excluding life-threatening conditions such as intracranial hemorrhage or large territorial infarction.

Unfortunately, CT has relatively low sensitivity for detecting early demyelinating lesions.

In the acute phase, approximately one-half of patients may have a completely normal non-contrast CT examination despite extensive abnormalities visible on MRI.

When abnormalities are present, CT may demonstrate:

  • Poorly defined hypoattenuating white matter lesions
  • Mild cerebral edema
  • Loss of gray-white matter differentiation
  • Rare mass effect
  • Multifocal bilateral lesions

Because these findings are nonspecific, CT alone cannot reliably distinguish ADEM from:

  • Acute ischemic stroke
  • Encephalitis
  • Brain tumors
  • Multiple sclerosis
  • CNS lymphoma

Therefore, any child presenting with rapidly progressive neurological deficits and an unrevealing CT should undergo urgent MRI whenever feasible.


MRI Pattern Recognition

Radiologists rely heavily on lesion distribution rather than a single imaging feature.

Typical MRI characteristics include:

Distribution

  • Bilateral
  • Multifocal
  • Asymmetric
  • Predominantly subcortical white matter
  • Deep white matter
  • Occasionally basal ganglia
  • Thalamus
  • Brainstem
  • Cerebellum
  • Spinal cord

Signal Characteristics

Typical lesions appear as

  • T2 hyperintense
  • FLAIR hyperintense
  • Variable T1 hypointensity
  • Patchy enhancement
  • Incomplete ring enhancement

Unlike chronic multiple sclerosis plaques, ADEM lesions tend to be:

  • larger
  • poorly marginated
  • more edematous
  • more confluent

The patient's MRI demonstrated multiple bilateral subcortical and deep white matter FLAIR hyperintense lesions with incomplete rim enhancement and peripheral diffusion restriction, imaging findings characteristic of active inflammatory demyelination.


Understanding Diffusion Restriction

One fascinating feature in this case is the presence of peripheral diffusion restriction.

Diffusion restriction is far less common in ADEM than in ischemic stroke.

When present, it probably reflects

  • dense inflammatory infiltrates
  • active macrophage accumulation
  • acute myelin destruction

Several studies suggest that diffusion restriction may correlate with:

  • more aggressive disease
  • greater inflammatory activity
  • slower radiologic recovery

Therefore, diffusion-weighted imaging (DWI) provides valuable prognostic information in addition to aiding diagnosis.


Spinal Cord Imaging

Spinal MRI significantly increases diagnostic confidence.

Typical ADEM spinal lesions are:

  • Long-segment
  • Intramedullary
  • Non-expansile
  • Patchy enhancement
  • Multiple vertebral levels

The thoracic lesion in this patient extended longitudinally across multiple segments without marked cord expansion, closely matching the classic imaging appearance of inflammatory demyelination.


Radiology Interpretation: Putting the Pieces Together

A neuroradiologist approaching this examination might reason as follows:

This systematic approach helps distinguish ADEM from other inflammatory, infectious, vascular, and neoplastic conditions.


Differential Diagnosis

ADEM shares imaging features with several serious neurological diseases. Accurate differentiation is essential because treatment strategies differ substantially.

DiseaseMRI PatternClinical Clues
ADEMLarge, bilateral, asymmetric white matter lesions; deep gray matter may be involvedUsually monophasic, it often follows infection or, rarely, vaccination
Multiple Sclerosis (MS)Smaller, well-defined periventricular plaques, corpus callosum involvementRelapsing-remitting course, older age group
Primary CNS LymphomaHomogeneously enhancing masses with marked diffusion restrictionProgressive focal deficits, often in immunocompromised patients
PRESSymmetric parieto-occipital vasogenic edemaHypertension, eclampsia, renal failure
MOG Antibody DiseaseExtensive demyelinating lesions similar to ADEMPositive MOG-IgG serology, recurrent episodes possible
Neuromyelitis Optica Spectrum Disorder (NMOSD)Longitudinal spinal cord lesions, optic neuritisPositive AQP4-IgG antibodies

The original case emphasized ADEM, atypical multiple sclerosis (including the Marburg variant), primary CNS lymphoma, and PRES as principal differential diagnoses.


ADEM versus Multiple Sclerosis

Because both disorders involve inflammatory demyelination, distinguishing them is one of the most important challenges in neuroradiology.

FeatureADEMMultiple Sclerosis
AgeMostly childrenYoung adults
Clinical CourseUsually monophasicRelapsing-remitting
LesionsLarge, poorly definedSmall, sharply marginated
DistributionSubcortical and deep white matterPeriventricular, juxtacortical, corpus callosum
Deep Gray MatterFrequently involvedLess common
Spinal CordLong-segment lesionsShort-segment lesions
Response to SteroidsTypically dramaticVariable

These imaging and clinical distinctions are critical for guiding diagnosis and management.


Diagnostic Workflow

An efficient diagnostic workflow helps avoid delays in treatment:

In the presented case, stereotactic biopsy revealed extensive macrophage-rich inflammatory infiltration with severe demyelination and relative axonal preservation, confirming an inflammatory demyelinating process rather than a neoplasm.


Why Imaging Follow-up Matters

Follow-up MRI is more than a routine check—it provides objective evidence of treatment response.

Radiologists look for:

  • Reduction in lesion size
  • Decreased FLAIR signal intensity
  • Resolution of diffusion restriction
  • Disappearance of contrast enhancement
  • Absence of new lesions

These changes support a monophasic inflammatory process and help differentiate ADEM from chronic relapsing diseases.

In this case, follow-up MRI demonstrated marked reduction in lesion size and FLAIR signal intensity with decreased diffusion restriction, findings consistent with clinical improvement after corticosteroids and IVIG.


Figure 3. Follow-up Brain MRI

Radiologic Interpretation

Follow-up axial MRI demonstrates substantial interval improvement. FLAIR hyperintensity within the white matter lesions has decreased, diffusion restriction has largely resolved, and the lesions have become less conspicuous on non-contrast T1-weighted imaging. These radiologic findings parallel the patient's neurological recovery and illustrate a favorable response to immunotherapy.

Figure 3. Follow-up brain MRI after treatment showing decreased FLAIR hyperintensity, reduced diffusion restriction, and regression of inflammatory demyelinating lesions, indicating successful therapeutic response.

Treatment of Acute Disseminated Encephalomyelitis (ADEM)

ADEM is a neurological emergency in which early immunotherapy can dramatically improve outcomes. The primary goal is to suppress the autoimmune inflammatory response, halt active demyelination, and promote neurological recovery before irreversible axonal injury occurs.

Unlike ischemic stroke, where reperfusion is the priority, the cornerstone of ADEM management is rapid immunomodulation.


First-Line Therapy: High-Dose Intravenous Corticosteroids

Intravenous methylprednisolone is considered the first-line treatment worldwide.

Typical regimen:

  • Methylprednisolone 20–30 mg/kg/day
  • Maximum 1 g/day
  • Administered for 3–5 days

Mechanisms of Action

Corticosteroids:

  • Suppress T-cell activation
  • Reduce cytokine production
  • Stabilize the blood-brain barrier
  • Decrease vasogenic edema
  • Limit macrophage-mediated myelin destruction

Clinical improvement often begins within several days if treatment is initiated promptly.

In the presented case, the patient began a 5-day course of intravenous corticosteroids on hospital day 2, with noticeable neurological improvement shortly thereafter.


Second-Line Therapy: Intravenous Immunoglobulin (IVIG)

When recovery is incomplete or symptoms remain severe, IVIG is commonly added.

Typical dosage:

  • 2 g/kg total
  • Administered over 2–5 days

How IVIG Works

IVIG exerts multiple immunomodulatory effects:

  • Neutralizes pathogenic antibodies
  • Inhibits complement activation
  • Modulates Fc receptor signaling
  • Reduces inflammatory cytokine release

In this case, IVIG was initiated on hospital day 8, followed by a transition to oral corticosteroids, resulting in further neurological recovery.


Plasma Exchange (PLEX)

For patients who fail to respond to corticosteroids and IVIG, plasma exchange is recommended.

Plasma exchange removes:

  • Autoantibodies
  • Immune complexes
  • Complement proteins
  • Pro-inflammatory mediators

Although randomized trials are limited due to the rarity of ADEM, numerous observational studies support its use in severe, refractory cases.


Rehabilitation

Recovery does not end with hospital discharge.

Many patients require multidisciplinary rehabilitation, including:

  • Physical therapy
  • Occupational therapy
  • Balance training
  • Gait rehabilitation
  • Cognitive rehabilitation (when indicated)

The child in this case regained bowel, bladder, and sensory function before discharge. Muscle strength improved substantially, although mild gait instability persisted and continued to improve during follow-up.


Prognosis

The prognosis for pediatric ADEM is generally favorable when diagnosis and treatment are timely.

Good Prognostic Factors

  • Early corticosteroid therapy
  • Monophasic disease course
  • Young age
  • Rapid clinical response
  • Radiologic improvement on follow-up MRI

Poor Prognostic Factors

  • Severe encephalopathy
  • Extensive spinal cord involvement
  • Persistent diffusion restriction
  • Delayed treatment
  • Recurrent demyelinating episodes

Most children recover with minimal or no long-term disability, although some may experience:

  • Fatigue
  • Mild motor weakness
  • Cognitive slowing
  • Balance difficulties

In this case, follow-up demonstrated marked neurological improvement with only mild residual fatigue, gait instability, and hip weakness after three months. MRI also showed substantial regression of the inflammatory lesions.


Key Takeaways

TopicClinical Pearl
DiseaseADEM is an acute autoimmune demyelinating disorder of the CNS.
Best ImagingContrast-enhanced MRI of the brain and spine is the diagnostic gold standard.
CT RoleCT is useful for emergency exclusion of hemorrhage but has limited sensitivity for ADEM.
Hallmark MRI FindingsMultifocal bilateral asymmetric T2/FLAIR hyperintense white matter lesions with variable enhancement.
Spinal ImagingLong-segment intramedullary lesions support the diagnosis.
Differential DiagnosisMultiple sclerosis, CNS lymphoma, MOG-associated disease, NMOSD, PRES, encephalitis.
First-Line TreatmentHigh-dose intravenous corticosteroids.
Adjunct TherapyIVIG or plasma exchange in refractory cases.
PrognosisExcellent in most children when treatment is initiated early.

Frequently Asked Questions (FAQ)

1. Is ADEM the same as multiple sclerosis?

No. ADEM is typically monophasic, meaning it occurs as a single inflammatory episode. Multiple sclerosis is a chronic, relapsing demyelinating disease characterized by recurrent attacks and new lesions over time.


2. Can a CT scan diagnose ADEM?

Not reliably. CT may appear normal or show nonspecific white matter hypoattenuation. MRI is far more sensitive and remains the preferred imaging modality for diagnosis.


3. Is ADEM life-threatening?

It can be. Severe cases may involve widespread brain inflammation, spinal cord dysfunction, respiratory compromise, or altered consciousness. Prompt diagnosis and treatment are therefore critical.


4. Does every patient recover completely?

Most children experience substantial recovery, but some may have persistent neurological deficits such as fatigue, weakness, cognitive impairment, or gait instability.


5. Can ADEM occur after vaccination?

Rare cases have been reported following various vaccinations, including COVID-19 vaccines. However, such events are exceedingly uncommon, and current evidence does not establish a causal relationship. The benefits of vaccination continue to outweigh these rare reported associations.


Quiz

Question 1

A 9-year-old child presents with acute multifocal neurological deficits. MRI shows bilateral asymmetric subcortical white matter lesions with incomplete ring enhancement. What is the most likely diagnosis?

A. Multiple sclerosis
B. Primary CNS lymphoma
C. Acute disseminated encephalomyelitis (ADEM)
D. Posterior reversible encephalopathy syndrome (PRES)
E. Progressive multifocal leukoencephalopathy

Correct Answer: C

Explanation: The combination of acute monophasic neurological symptoms and characteristic MRI findings strongly supports ADEM. Multiple sclerosis typically presents with smaller, well-defined periventricular lesions, whereas PRES predominantly affects the posterior circulation, with symmetric vasogenic edema.


Question 2

Which imaging modality is considered the gold standard for evaluating suspected ADEM?

A. Skull radiography
B. CT angiography
C. Brain MRI with contrast
D. PET/CT
E. Ultrasound

Correct Answer: C

Explanation: Contrast-enhanced MRI best demonstrates white matter lesions, spinal cord involvement, enhancement patterns, and diffusion abnormalities that are essential for diagnosis.


Question 3

What is the recommended first-line treatment for ADEM?

A. Antibiotics
B. Surgical decompression
C. High-dose intravenous corticosteroids
D. Anticoagulation
E. Radiation therapy

Correct Answer: C

Explanation: High-dose intravenous corticosteroids rapidly suppress autoimmune inflammation and are the internationally accepted first-line therapy. IVIG and plasma exchange are reserved for patients with inadequate responses.


Recommended Reading

  1. R. K. Garg, "Acute disseminated encephalomyelitis," Postgraduate Medical Journal, vol. 79, pp. 11–17, 2003. DOI: https://doi.org/10.1136/pmj.79.927.11
  2. Y. J. Lee, "Acute disseminated encephalomyelitis in children," Korean Journal of Pediatrics, 2011. DOI: https://doi.org/10.3345/kjp.2011.54.6.234
  3. N. Sarbu et al., "White Matter Diseases with Radiologic–Pathologic Correlation," RadioGraphics, 2016. DOI: https://doi.org/10.1148/rg.2016160031
  4. M. Bester and M. Inglese, "Neuroimaging of Multiple Sclerosis, Acute Disseminated Encephalomyelitis, and Other Demyelinating Diseases," Seminars in Roentgenology, 2014. DOI: https://doi.org/10.1053/j.ro.2013.09.002
  5. G. S. Manzano et al., "Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID-19," Neurology: Neuroimmunology & Neuroinflammation, 2021. DOI: https://doi.org/10.1212/NXI.0000000000001080
  6. Y. Wang et al., "SARS-CoV-2-associated acute disseminated encephalomyelitis: A systematic review," Journal of Neurology, 2022. DOI: https://doi.org/10.1007/s00415-021-10771-8
  7. N. P. Young et al., "Perivenous demyelination: Association with clinically defined ADEM and comparison with multiple sclerosis," Brain, 2010. DOI: https://doi.org/10.1093/brain/awp321

Comments

Popular posts from this blog

Understanding Tubal Ligation Clips: Imaging, Risks, Migration, and Management

Teres Minor Atrophy: Causes, Imaging, and Clinical Implications

The Lethal Lens: Mastering the Diagnosis and Management of Epidural Hemorrhage (EDH)